Dr Reddy’s Laboratories has signed a licensing deal with Shanghai Henlius Biotech to develop and commercialize HLX15, a biosimilar of Johnson & Johnson’s (NYSE: JNJ) Darzalex (daratumumab) for ...
A recombinant anti-CD38 fully human monoclonal antibody injection, HLX15 comes in both intravenous and subcutaneous ...
Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has ...
Mahindra & Mahindra, LIC, Mazagon Dock Shipbuilders, NHPC, Oil India, Wockhardt, 3M India, Archean Chemical Industries, AIA Engineering, Akzo Nobel India, Alembic, Alkem Laboratories, Astra Microwave ...
Shanghai Henlius Biotech, Inc. (“Henlius”) announced FDA acceptance of the Biologics License Application (BLA) for ...
Dr. Reddy's (RDY) partners with Shanghai Henlius Biotech to develop and market biosimilar versions of J&J's (JNJ) multiple ...
Dr. Reddy’s to develop and commercialize biosimilar candidate for Johnson & Johnson’s Darzalex drugs with Shanghai Henlius Biotech.
HYDERABAD: Dr Reddy’s Laboratories SA, the wholly-owned Swiss subsidiary of Hyderabad-based pharma biggie Dr Reddy’s ...
Hong Kong-listed Shanghai Henlius Biotech Inc, a subsidiary of Fosun Pharma, announced on Wednesday that its anti-PD-1 mAb, ...
Get Deependra Goyal News on Telangana Today, Deependra Goyal latest news, Deependra Goyal news, | Telangana Today ...
Get Gummadidala farmers News on Telangana Today, Gummadidala farmers latest news, Gummadidala farmers news, | Telangana Today ...
New Delhi: Dr Reddy’s Laboratories on Thursday said its subsidiary has inked a licence agreement with Shanghai Henlius ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results